Immunogenicity of a recombinant Mycobacterium bovis bacille Calmette-Guèrin expressing malarial and tuberculosis epitopes

Vaccine

Volumn 24, Issue 17, 2006, Pages 3646-3653

  Rapeah, S ^a   Norazmi, M N ^a  

^a SCHOOL OF HEALTH SCIENCES   (Malaysia)

Author keywords

Malaria; Recombinant BCG; Tuberculosis

Indexed keywords

(NANP)3 ANTIGEN; BCG VACCINE; EPITOPE; ESAT 6 ANTIGEN; F2R(II)EBA ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 2; PARASITE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CODON USAGE; CONTROLLED STUDY; DRUG EFFECT; FLOW CYTOMETRY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; MALARIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TUBERCULOSIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BCG VACCINE; CARRIER PROTEINS; CYTOKINES; EPITOPES, T-LYMPHOCYTE; IMMUNIZATION; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MALARIA VACCINES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PROTOZOAN PROTEINS; VACCINES, SYNTHETIC;

EID: 33645238933     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.01.053     Document Type: Article

References (54)

1. M.N. Norazmi, and J.W. Dale Cloning and expression of a candidate malaria epitope in bacille Calmette-Guèrin Biotech Lett 19 1997 1135 1137
2. F. Haeseleer, J.F. Pollet, M. Haumont, A. Bollen, and P. Jacobs Stable integration and expression of the Plasmodium falciparum circumsporozoite protein coding sequence in mycobacteria Mol Biochem Parasitol 57 1993 117 126
3. S. Matsumoto, H. Yukitake, H. Kanbara, and T. Yamada Recombinant Mycobacterium bovis bacillus Calmette-Guèrin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies J Exp Med 188 1998 845 854
4. C. Zheng, P. Xie, and Y. Chen Immune response induced by recombinant BCG expressing merozoite surface antigen 2 from Plasmodium falciparum Vaccine 20 2002 914 919
5. M.A. Horwitz, G. Harth, B.J. Dillon, and S. Maslesa-Galic Recombinant bacillus Calmette-Guèrin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model Proc Natl Acad Sci USA 97 2000 13853 13858
6. L. Bao, W. Chen, H. Zhang, and X. Wang Virulence immunogenicity and protective efficacy of two recombinant Mycobacterium bovis bacillus Calmette-Guèrin strain expressing the antigen ESAT-6 from Mycobacterium tuberculosis Infect Immun 71 2003 1656 1661
7. W.J. Britton, and U. Palendira Improving vaccine against tuberculosis Immunol Cell Biol 81 2003 34 45
8. World Health Organization. World malaria situation in 1994. Weekly Epidem Rec 1997; 72:269-74.
9. M.F. Good, D.C. Kaslow, and L.H. Miller Pathway and strategies for developing a malaria blood stage vaccine Ann Rev Immunol 16 1998 57 87
10. R.S. Nussenzweig, and C.A. Long Malaria vaccines: multiple targets Science 265 1994 1381 1383
11. R.S. Phillips Current status of malaria and potential for control Clin Microbiol Rev 14 2001 208 226
12. World Health Organization. Tuberculosis control in the WHO Western Pacific Region. Manila:WHO Regional office for the Western Pacific Region. 2001.
13. H.G. ten-Dam Research on BCG vaccination Adv Tuberc Res 21 1984 79 106
14. P.F. Fine Variation in protection by BCG: implications of and for heterologous immunity Lancet 346 1995 1339 1345
15. C.R. Frieden, A. Sterling, J. Pablos-Mendez, J.O. Kilburn, G.M. Cauthen, and S.W. Dooley The emergence of drug-resistant tuberculosis in New York city N Eng J Med 328 1993 521 526
16. M.A. Espinal, A. Laszlo, L. Simonsen, F. Boulahbal, S.J. Kim, and A. Reniero Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against tuberculosis and lung disease working group on anti-tuberculosis drug resistance surveillance N Engl J Med 344 2001 1294 1303
17. B.K. Sim, P.A. Orlandi, J.D. Haynes, F.W. Klotz, J.M. Carter, and D. Camus Primary struture of the 175K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion J Cell Biol 111 1990 1877 1884
18. H. Liang, D.L. Narum, S.R. Fuhrmann, T. Luu, and BK.L. Sim A recombinant baculovirus-expressed Plasmodium falciparum receptor-binding domain of erythrocyte binding protein EBA-175 biologically mimics native protein Infect Immun 68 2000 3564 3568
19. F. Zavala, A.H. Cochrane, E.H. Nardin, R.S. Nussenzweig, and V. Nussenzweig Circumsporozoite proteins of malaria parasites contain a single imunodominant region with two or more identical epitopes J Exp Med 157 1983 1947 1954
20. W.R. Ballou, S.L. Hoffman, J.A. Sherwood, M.R. Hollingdale, F.A. Neva, and W.T. Hockmeyer Safety and efficacy of recombinant Plasmodium falciparum sporozoite DNA vaccine Lancet 1 1987 1277 1281
21. L. Brandt, T. Oettinger, A. Holm, A.B. Anderson, and P. Anderson Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis J Immunol 157 1996 3527 3533
22. L.A. van Pinxteren, P. Ravn, E.M. Agger, J. Pollock, and P. Anderson Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10 Clin Diagn Lab Immunol 7 2000 155 160
23. C. Manca, K. Lyashchenko, H.G. Wiker, D. Usai, R. Colangeli, and M.A. Gennaro Molecular cloning, purification, and serological characterization of MPT63, a novel antigen secreted by Mycobacterium tuberculosis Infect Immun 65 1997 16 23
24. W.P.C. Stemmer, A. Crameri, K.D. Ha, T.M. Brennan, and H.L. Heynecker Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides Gene 164 1995 49 53
25. M.N. Norazmi, Z.F. Zainuddin, R. Suppian, and J.W. Dale The use of assembly polymerase chain reaction for cloning of a malarial epitope into Mycobacterium smegmatis-importance of overcoming codon bias Biotech Tech 13 1999 485 489
26. A. Labidi, H.L. David, and D. Roulland-Dussoix Restriction endonuclease mapping and cloning of Mycobacterium fortuitum var. fortuitum plasmid pAL5000 Ann Inst Pasteur Microbiol 136 1985 209 215
27. J.L. Flynn Recombinant BCG as an antigen delivery system Cell Mol Biol 40 1994 31 36
28. C. Hetzel, R. Janssen, S.J. Ely, N.M. Kristensen, K. Bunting, and J.B. Cooper An epitope delivery system for use with recombinant mycobacteria Infect Immun 66 1998 3643 3648
29. W.G. Metzger, D.M.N. Okenu, D.R. Cavanagh, J.V. Robinson, K.A. Bojang, and H.A. Weiss Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk to malaria Parasite Immunol 25 2003 307 312
30. O. Garraud, R. Perraut, A. Diouf, W.S. Nambei, A. Tall, and A. Spiegel Regulation of antigen-specific immunoglobulin G subclasses in response to conserved and polymorphic Plasmodium falciparum antigens in an in vitro model Infect Immun 70 2002 2820 2827
31. E.C. Smith, and A.W. Taylor-Robinson Parasite-specific immunoglobulin isotypes during lethal and non-lethal murine malaria infections Parasitol Res 89 2003 26 33
32. T. Germann, M. Bongartz, H. Dlugonska, H. Hess, E. Schmitt, and L. Kolbe Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo Eur J Immunol 25 1995 823 829
33. P. Xin-Li, and T. Horii Complement-mediated killing of Plasmodium falciparum erythrocytic schizont with antibodies to the recombinant serine repeat antigen (SERA) Vaccine 16 1998 1299 1305
34. L.M. Kumaratilake, A. Ferrante, T. Jaeger, and S.D. Morris-Johns The role of complement, antibody and tumor necrosis factor alpha in the killing of Plasmodium falciparum by the monocytic cell line THP-1 Infect Immun 65 1997 5342 5345
35. S. Waki, S. Uehara, K. Kanbe, K. Ono, M. Suzuki, and H. Nariuchi The role of T cells in pathogenesis and protective immunity to murine malaria Immunol 75 1992 646 651
36. M.M. Steven, M.F. Tam, S.F. Wolf, and A. Sher IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-γ and TNF-α and occurs via a nitric oxide-dependent mechanism J Immunol 155 1995 2545 2556
37. N. Dhar, V. Rao, and A.K. Tyagi Skewing of the Th1/Th2 responses in mice due to variation in the level of expression of an antigen in a recombinant BCG system Immunol Lett 88 2003 175 184
38. S. Matsumoto, H. Yukitake, H. Kanbara, H. Yamada, A. Kitamura, and T. Yamada Mycobacterium bovis bacillus Calmette-Guèrin induces protective immunity against infection by Plasmodium yoelii at blood-stage depending on shifting immunity toward Th1 type and inducing protective IgG2a after the parasite infection Vaccine 19 2000 779 787
39. U. D'Alessandro, A. Leach, C.J. Drakeley, S. Bennett, B.O. Olaleye, and G.W. Fegan Efficacy trial of malaria vaccine SPf66 in Gambian infants Lancet 346 1995 462 467
40. M. Walther, S. Dunachie, S.M. Keating, J. Vuola, T. Berthoud, and A. Schmidt Safety, immunogenicity and efficacy of a pre-erythrocytic malaria candidate vaccine, ICC-1132 formulated in Seppic ISA 720 Vaccine 23 2005 857 864
41. L.J.M. Carvalho, C.T. Daniel-Ribeiro, and H. Goto Malaria vaccine: candidate antigens, mechanisms, constraints and prospects Scand J Immunol 56 2002 327 343
42. Z. Zhou, L. Xiao, O.H. Branch, S. Kariuki, B.L. Nahlen, and A.A. Lal Antibody responses to repetitive epitopes of the circumsporozoite protein, liver stage antigen-1, and merozoite surface protein-2 in infants residing in a Plasmodium falciparum-hyperendemic area of western Kenya. XIII. Asembo Bay Cohort Project Am J Trop Med Hyg 66 2002 7 12
43. J.L. Flynn Immunology of tuberculosis and implications in vaccine development Tuberculosis 84 2004 93 101
44. R. Van Crevel, T.H.M. Ottenhoff, and J.W.M. van der Meer Innate Immunity to Mycobacterium tuberculosis Clin Microbiol Rev 15 2002 294 309
45. S.G. Reed, M.R. Alderson, W. Dalemans, Y. Lobet, and Y.A.W. Skeiky Prospects for a better vaccine against tuberculosis Tuberculosis 83 2003 213 219
46. S. Young, M. O'Donnell, E. Lockhart, B. Buddle, L. Slobb, and Y. Luo Manipulation of immune responses to Mycobacterium bovis by vaccination with IL-2- and IL-18-secreting recombinant bacillus Calmette-Guèrin Immunol Cell Biol 80 2002 209 215
47. M.A. O'Donnell, A. Aldovini, and R. Duba Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes Infect Immun 62 1994 2508 2514
48. F.C. Minion, S.A. Menon, G.G. Mahairas, and M.J. Wannemuehler Enhanced murine antigen-specific gamma interferon and immunoglobulin G2a responses by using mycobacterial ESAT-6 sequences in DNA vaccines Infect Immun 71 2003 2239 2243
49. L. Brandt, M. Elhay, I. Rosenkrands, E.B. Lindblad, and P. Andersen ESAT-6 subunit vaccination against Mycobacterium tuberculosis Infect Immun 68 2000 791 795
50. J. Wakeham, J. Wang, and Z. Xing Genetically determined disparate innate and adaptive cell-mediated immune responses to pulmonary Mycobacterium bovis BCG infection in C57BL/6 and BALB/c mice Infect Immun 68 2000 6946 6953
51. V.L. Bonato, E.D. Goncalves, R.R. Santos, and C.L. Silva Genetic aspects and microenvironment affect expression of CD18 and VLA-4 in experimental tuberculosis Scand J Immunol 56 2002 185 194
52. A.E. Goldfeld, J.C. Delgado, S. Thim, M.V. Bozon, A.M. Uglialoro, and D. Turbay Association of an HLA-DQ allele with clinical tuberculosis JAMA 279 1998 226 228
53. A. Alissa, and S.M. Chackerian Behar Susceptibility to Mycobacterium tuberculosis: lesson from inbred strain of mice Tuberculosis 83 2003 279 285
54. L.D. Hazlett, S. McClellan, B. Kwon, and R. Barrett Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive Invest Ophthalmol Vis Sci 41 2000 805 810